Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
NVONovo Nordisk A/S Live data
$40.74▲ +0.04 (0.1%)as of Nov 11, 2026, 6:25 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$35.12$64.16
1-Month Range
Month up 7.0%
$38.06$42.18
Daily Price Range
Day up 0.1%
$40.10$40.80
Volume
vs 12M avg
6M12M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$135.7B
Short % of Float—
Employees—
Sales—
Shares Outstanding3,331,860,579
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.nvo.com
Novo Nordisk A/S — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- Current ratio below 1 (0.87)
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
90
Growth
63
Quality
95
Sentiment
46
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for NVO.
Price targets unavailable — no 12-month targets on file for NVO.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on NVO, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:25 PM UTC